For the quarter ending 2026-01-02, VREX had -$25,400K decrease in cash & cash equivalents over the period. -$26,800K in free cash flow.
| Cash Flow | 2026-01-02 | 2025-10-03 | 2025-07-04 |
|---|---|---|---|
| Gain on purchase of business | - | 0 | 0 |
| Net income (loss) | 2,400 | 12,200 | -82,100 |
| Impairment of goodwill | - | 0 | 93,900 |
| Share-based compensation expense | 3,800 | 3,400 | 11,600 |
| Depreciation | 5,700 | 5,600 | 17,600 |
| Amortization of intangible assets | 1,100 | 1,100 | 2,900 |
| Deferred taxes | 600 | 2,700 | -3,200 |
| Loss from equity method investments | -3,200 | -200 | -2,500 |
| Impairment of equity method investment | - | 0 | - |
| Amortization of deferred loan costs | -500 | -400 | -2,300 |
| Inventory write-down | 1,100 | 800 | 3,000 |
| Other, net | -500 | 2,000 | -200 |
| Accounts receivable | -8,900 | 20,100 | -20,200 |
| Inventories, net | 30,100 | 2,300 | 37,600 |
| Prepaid expenses and other assets | 2,100 | -1,700 | 5,300 |
| Accounts payable | 12,100 | -5,400 | 11,600 |
| Accrued liabilities and other current and long-term liabilities | -23,800 | 11,500 | -11,400 |
| Deferred revenues | 0 | -1,900 | 7,600 |
| Net cash (used in) provided by operating activities | -16,100 | 7,900 | 33,800 |
| Purchases of property, plant, and equipment | 10,700 | 5,600 | 17,300 |
| Loss on settlement of cash flow hedge | - | 0 | - |
| Purchase of marketable equity securities | - | 0 | 0 |
| Settlement of net investment hedge | - | 0 | 800 |
| Proceeds from sales of marketable debt securities | 0 | 1,000 | 10,500 |
| Acquisitions of businesses, net of cash acquired | - | 0 | 0 |
| Proceeds from maturities of marketable debt securities | 4,000 | 5,200 | 45,300 |
| Purchase of certificates of deposit | - | 0 | - |
| Purchase of marketable debt securities | 0 | 0 | 30,600 |
| Proceeds from maturities of certificates of deposit | 0 | 0 | 3,400 |
| Other, net | 1,000 | 1,300 | -500 |
| Net cash used in investing activities | -7,700 | -700 | 11,000 |
| Taxes related to net share settlement of equity awards | 1,500 | 0 | 1,900 |
| Proceeds from issuance of senior secured notes | 0 | 0 | 126,900 |
| Repayments of borrowings | 0 | 400 | 201,500 |
| Proceeds from exercise of stock options | - | 0 | - |
| Payment of debt issuance costs | - | 0 | 1,200 |
| Proceeds from shares issued under employee stock purchase plan | - | 1,600 | 1,700 |
| Other, net | -100 | -100 | -1,000 |
| Net cash (used in) provided by financing activities | -1,600 | 1,100 | -77,000 |
| Effects of exchange rate changes on cash and cash equivalents and restricted cash | - | 300 | 300 |
| Net (decrease) increase in cash and cash equivalents and restricted cash | -25,400 | 8,600 | -31,900 |
| Cash and cash equivalents at beginning of period | 147,100 | 170,400 | - |
| Cash and cash equivalents at end of period | 121,700 | 147,100 | - |
Varex Imaging Corp (VREX)
Varex Imaging Corp (VREX)